News Releases from Region 03
Jubilant Cadista Pharmaceuticals Settles Hazardous Waste Violations At Salisbury, Md. Facility
PHILADELPHIA (July 13, 2017) – The U.S. Environmental Protection Agency today announced an agreement with Jubilant Cadista Pharmaceuticals Inc., that resolves alleged violations of hazardous waste regulations at the company’s pharmaceutical manufacturing facility in Salisbury, Maryland. The agreement addresses compliance with environmental regulations that help protect communities and the environment from potential exposure to hazardous waste.
EPA cited Jubilant Cadista Pharmaceuticals Inc. for violating the Resource Conservation and Recovery Act (RCRA), the federal law governing the treatment, storage, and disposal of hazardous waste. RCRA is designed to protect public health and the environment, and avoid long and extensive cleanups, by requiring the safe, environmentally sound storage and disposal of hazardous waste.
The hazardous waste included lab solvents and corrosive cleaner waste. Violations included:
- Storage of hazardous waste on-site in excess of the 90-day storage limitation.
- Failure to clearly label or date hazardous waste containers.
- Failure to keep hazardous waste containers closed.
- Failure to maintain job titles and descriptions for employees responsible for handling hazardous waste.
- Failure to maintain an adequate contingency plan.
- Failure to submit a timely and complete biennial report.
As part of the agreement, Jubilant Cadista Pharmaceuticals Inc. will pay a $35,000 penalty. The settlement reflects the company’s compliance efforts, and its cooperation with EPA. As part of the settlement, the company has not admitted liability, but has certified its compliance with applicable RCRA requirements.
For more information about hazardous waste and RCRA, visit http://www.epa.gov/epawaste/hazard/index.htm
# # #